Affiliation:
1. Illicit Drugs Laboratory, Applied Sciences Group Health Sciences Authority Singapore
Abstract
AbstractThe identification of the synthetic cannabinoids receptor agonists (SCRAs) has always posed a great challenge to drug testing laboratories with slight structural modifications aimed at evading drug legislation. In addition, the most prevalent synthetic cannabinoids have valine and tert‐leucine amino acid moieties where re‐arrangement of the carbon chains can result in structural isomers that are very similar to the parent synthetic cannabinoids. This makes their analysis and identification challenging, and the problem is compounded with the difficulty in purchasing reference standards quickly and a lack of literature for comparison. Therefore, in this investigation, four series of synthetic cannabinoids (AB‐PINACA, AB‐CHMINACA, MMB‐FUBINACA and 5‐fluoro‐MDMB‐PINACA) and their alkyl chain structural isomers at the amino acid moieties were synthesized and characterized using various analytical techniques—gas chromatography–mass spectrometry (GC–MS), gas chromatography–infrared detection (GC–IRD) and nuclear magnetic resonance (NMR) spectroscopy to evaluate the ability of each analytical technique to differentiate the respective isomers for their identification. A total of 12 isomers were synthesized and analysed together with the four parent synthetic cannabinoids. NMR was able to differentiate between all the compounds, whereas GC–IRD was able to discern between most of the synthetic cannabinoids and their isomers. GC–MS had the least discriminating power and was not able to differentiate some of the compounds that has very similar mass spectra. The results from this work will be useful to other drug testing laboratories that are facing the identification of related synthetic cannabinoids.
Subject
Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry
Reference27 articles.
1. United Nation Office on Drugs and Crime Current NPS threatsVol.52022. Accessed January 27 2023.https://www.unodc.org/documents/scientific/Current_NPS_Threats_V.pdf
2. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution
3. United Nations Office on Drugs and Crime The challenge of new psychoactive substances – a report from the global SMART Programme2013. Accessed April 12 2022.http://www.unodc.org/documents/scientific/NPS_Report.pdf
4. Drugs analysis and citizens safety. Workflows for chemical analysis and structural elucidation of new psychoactive substances in the EU